Decision primer

Make the next decision smaller

You do not have to decide whether “peptides” are good or bad. Decide whether this one offer answers five basic questions.

THE FIVE CHECKS

Five checks, one at a time

1. PersonCan the clinician be found in the right Texas record?
2. ProductIs the exact name, form and approval status clear?
3. PharmacyCan the pharmacy’s registered name be verified?
4. PriceIs the full recurring cost written down?
5. PlanIs follow-up available after payment?

HARD STOP

Some answers do not need more comparison

As of September 2026, federal rules required a prescription for prescription medicine. A compounded drug could not be called FDA-approved. FDA also rejected research labels as a route for selling human treatment.

A lower price does not make up for a missing prescription, a false approval claim or a research-only label.

PAUSE IS A DECISION

Missing information can wait

Save the page. Ask the questions. Compare the written answers with the public records. Walking away from an unclear offer is a complete next step.